| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 01/24/2013 | US20130023503 Nk1 antagonists |
| 01/24/2013 | US20130023497 Triazine Derivatives and their Therapeutical Applications |
| 01/24/2013 | US20130023495 Uses of dgat1 inhibitors |
| 01/24/2013 | US20130023492 Pharmaceutical compositions comprising plant-based polysaccharides and uses thereof |
| 01/24/2013 | US20130023483 Template-fixed peptidomimetics with cxcr7 modulating activity |
| 01/24/2013 | US20130023482 Crystalline form of cyclosporine a, methods of preparation, and methods for use thereof |
| 01/24/2013 | US20130022680 Modalities for the treatment of degenerative diseases of the retina |
| 01/24/2013 | US20130022644 Novel n-phenylacetamide derivatives, which inhibit the enzyme soat-1, and pharmaceutical and cosmetic compositions containing them |
| 01/24/2013 | US20130022615 Compositions and Methods for Antibodies Targeting Complement Protein C5 |
| 01/24/2013 | US20130022587 Cycloalkyl-Substituted Imidazole Derivative |
| 01/24/2013 | US20130022580 Preparation and use of meristematic cells belonging to the dendrobium phalaenopsis, anisellia, polyrrhiza, vanilla, cattleya and vanda genera with high content of phenylpropanoids, hydrosoluble polysaccharides and extensins |
| 01/24/2013 | US20130022551 DEspR ANTAGONISTS AND AGONISTS AS THERAPEUTICS |
| 01/24/2013 | CA2842352A1 3-(fluorvinyl)pyrazoles and the use thereof |
| 01/24/2013 | CA2841969A1 Fixed dose combination of bimatoprost and brimonidine |
| 01/23/2013 | EP2548880A2 Compositions for increasing telomerase activity |
| 01/23/2013 | EP2548563A1 Anti-allergic composition |
| 01/23/2013 | EP2548552A2 Titration package for 1-amino-alkylcylohexanes |
| 01/23/2013 | EP2547340A2 Ophthalmic formulations of cetirizine and methods of use |
| 01/23/2013 | EP2547323A2 Pharmaceutical composition for treatment of increased intraocular pressure |
| 01/23/2013 | CN1606545B Pyrrolidine and piperidine derivates as nk1 antagonists |
| 01/23/2013 | CN102892432A Anti-cd160 specific antibodies for the treatment of eye disorders based on neoangiogenesis |
| 01/23/2013 | CN102887954A Human anti-il-23 antibodies, compositions, methods and uses |
| 01/23/2013 | CN102885925A Chinese medicinal preparation for treating deficiency of qi and blood, qi stagnation and blood stasis |
| 01/23/2013 | CN102885916A Traditional Chinese medicine composition for oral medication of canine corneal ulcer |
| 01/23/2013 | CN102885913A Fresh essential balm |
| 01/23/2013 | CN102885849A Use of biocompatible polymers for the preparation of a composition or a medical device |
| 01/23/2013 | CN102885803A Application of felbinac tromethamine salt to preparation of medicine for treating eye inflammatory reactions |
| 01/23/2013 | CN102885769A Novel pranoprofen eye drop and preparation method thereof |
| 01/23/2013 | CN102885768A Pranoprofen in-situ gelling eye drop and preparation method thereof |
| 01/23/2013 | CN102885767A Novel olopatadine hydrochloride eye drop and preparation method thereof |
| 01/23/2013 | CN102885764A New preparation method of acetylcysteine gel |
| 01/23/2013 | CN102228626B Traditional Chinese medicine for treating tinnitus and deafness |
| 01/23/2013 | CN102210645B Lutein ophthalmic nanocapsule in-situ gel preparation and preparation method thereof |
| 01/23/2013 | CN102198087B Preservative-free ophthalmic in-situ gelling agent and preparation method thereof |
| 01/23/2013 | CN102138895B Eyedrops containing fasudil hydrochloride and preparation method thereof |
| 01/23/2013 | CN101721431B Compound nano pearl starch ball and production process thereof |
| 01/23/2013 | CN101657192B Medicinal composition, food or drink having effect of enhancing parasympathetic nervous actions |
| 01/23/2013 | CN101555221B Producing method of prostaglandin F-type derivant |
| 01/22/2013 | CA2602610C Benzimidazole compound |
| 01/22/2013 | CA2338524C Inhibitors of urokinase and blood vessel formation |
| 01/22/2013 | CA2329267C A method of modulating the efficiency of translation termination and degradation of aberrant mrna involving a surveillance complex comprising human upflp, eucaryotic release factor 1 and eucaryotic release factor 3 |
| 01/17/2013 | WO2013009586A1 Topical minocycline ointment for suppression of allergic skin responses |
| 01/17/2013 | WO2013009543A1 Polycyclic pyrrolidine-2,5-dione derivatives as -formyl peptide receptor like-1 (fprl-1) receptor modulators |
| 01/17/2013 | WO2013009378A1 Use of xanthophyll carotenoids to improve visual performance and neural efficiency |
| 01/17/2013 | WO2013008872A1 Novel compound having parp inhibitory activity |
| 01/17/2013 | WO2013008716A1 Aqueous ophthalmic composition |
| 01/17/2013 | WO2013008715A1 Aqueous ophthalmic composition |
| 01/17/2013 | WO2013008714A1 Ophthalmic aqueous composition |
| 01/17/2013 | WO2013007766A1 Means and methods for the treatment of pathological angiogenesis |
| 01/17/2013 | WO2009013563A3 Use of lipid conjugates in the treatment of diseases or disorders of the eye |
| 01/17/2013 | US20130018299 Nanoshells on polymers |
| 01/17/2013 | US20130018085 iRNA Agents Targeting VEGF |
| 01/17/2013 | US20130018081 AChE ANTISENSE OLIGONUCLEOTIDE AS AN ANTI-INFLAMMATORY AGENT |
| 01/17/2013 | US20130018077 Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders |
| 01/17/2013 | US20130018071 Solid Forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
| 01/17/2013 | US20130018070 Modulators of cystic fibrosis transmembrane conductance regulator |
| 01/17/2013 | US20130018068 Spirocycles as inhibitors of 11-beta hydroxyl steroid dehydrogenase type 1 |
| 01/17/2013 | US20130018067 Polycyclic pyrrolidine-2,5-dione derivatives as -formyl peptide receptor like-1 (fprl-1) receptor modulators |
| 01/17/2013 | US20130018057 Quinoline and Quinoxaline Derivatives as Kinase Inhibitors |
| 01/17/2013 | US20130018052 2-pyridyl substituted imidazoles as alk5 and/or alk4 inhibitors |
| 01/17/2013 | US20130018051 Bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 01/17/2013 | US20130018038 Chemical compounds |
| 01/17/2013 | US20130018036 Substituted indazole derivatives active as kinase inhibitors |
| 01/17/2013 | US20130018031 Aminoalkylpyrimidine derivatives as histamine h4 receptor antagonists |
| 01/17/2013 | US20130018028 Bi-(indole-2-aceto)-iron II (Ferrous Indole Acetate) |
| 01/17/2013 | US20130018024 Methods and systems for pharmacogenomic treatment of cardiovascular conditions |
| 01/17/2013 | US20130018019 Aromatic compounds having sphingosine-1-phosphonate (s1p) receptor activity |
| 01/17/2013 | US20130017996 Muteins of tear lipocalin and methods for obtaining the same |
| 01/17/2013 | US20130017268 Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof |
| 01/17/2013 | US20130017244 Sustained release intraocular implants and related methods |
| 01/17/2013 | US20130017243 Sustained-release reservoir implants for intracameral drug delivery |
| 01/17/2013 | US20130017209 A-beta binding polypeptides |
| 01/17/2013 | US20130017197 Stabilized antibody preparations and uses thereof |
| 01/17/2013 | US20130017189 Functionalised Triblock Copolymers and Compositions Containing Such Polymers |
| 01/17/2013 | US20130017188 Modulation of sgk1 expression in th17 cells to modulate th17-mediated immune responses |
| 01/17/2013 | US20130017169 Multimeric forms of therapeutic proteins and uses thereof |
| 01/17/2013 | US20130017149 Pharmaceutical compounds |
| 01/17/2013 | CA2841983A1 Polycyclic pyrrolidine-2,5-dione derivatives as -formyl peptide receptor like-1 (fprl-1) receptor modulators |
| 01/17/2013 | CA2841897A1 Novel compound having parp inhibitory activity |
| 01/17/2013 | CA2841411A1 Use of xanthophyll carotenoids to improve visual performance and neural efficiency |
| 01/16/2013 | EP2545925A1 Compositions comprising hyaluronic acid for treating and preventing mucosa related diseases |
| 01/16/2013 | EP2545025A1 Synthesis of alpha-tocopherolquinone derivatives, and methods of using the same |
| 01/16/2013 | EP2544677A2 Beta -adrenergic receptor agonists and uses thereof |
| 01/16/2013 | CN102884073A Peptides for promoting angiogenesis and a use thereof |
| 01/16/2013 | CN102884067A Prophylactic or therapeutic medication for inner ear disorders |
| 01/16/2013 | CN102884047A 2-pyridone compounds |
| 01/16/2013 | CN102884037A Synthesis of alpha-tocopherolquinone derivatives, and methods of using the same |
| 01/16/2013 | CN102883733A AGE production inhibitor |
| 01/16/2013 | CN102883715A Chitosan-containing protective composition |
| 01/16/2013 | CN102875677A Humanized anti-egfl7 antibodies and methods using same |
| 01/16/2013 | CN102875676A Human anti-human VEGF monoclonal antibody molecule and application thereof |
| 01/16/2013 | CN102875478A Amine salts of a crth2 antagonist |
| 01/16/2013 | CN102875441A Plexxikon inc |
| 01/16/2013 | CN102872464A Novel choroidal neovascularization gene therapeutic medicine and use thereof |
| 01/16/2013 | CN102872463A Nanoparticles comprising rna ligands |
| 01/16/2013 | CN102872368A Chinese medicine acupoint application preparation for purging fire for removing toxin |
| 01/16/2013 | CN102872279A Tablets for clearing away lower energizer and dampness-heat |
| 01/16/2013 | CN102872263A Inflammation relieving and eyesight improving eye drop |
| 01/16/2013 | CN102872237A Skunk bugbane spleen-qi raising tablet |
| 01/16/2013 | CN102872221A Traditional Chinese medicine fumigating and washing liquid for treating keratitis |